Your browser doesn't support javascript.
loading
Compound Kushen Injection Reduces Severe Toxicity and Symptom Burden Associated With Curative Radiotherapy in Patients With Lung Cancer.
Liu, Jie; Yu, Qingxi; Wang, Xin Shelley; Shi, Qiuling; Wang, Jun; Wang, Fan; Ren, Simeng; Jin, Jiayue; Han, Baojin; Zhang, Wenzheng; Su, Xueyao; Yuan, Shuanghu; Lin, Hongsheng.
Affiliation
  • Liu J; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Yu Q; Department of Radiation Oncology, Shandong Cancer Hospital, Shandong, China.
  • Wang XS; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Shi Q; School of Public Health, Chongqing Medical University, Chongqing, China.
  • Wang J; Department of Radiation Oncology, Hebei Tumor Hospital, Hebei, China.
  • Wang F; Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Anhui, China.
  • Ren S; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Jin J; Beijing University of Chinese Medicine, Beijing, China.
  • Han B; Beijing University of Chinese Medicine, Beijing, China.
  • Zhang W; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
  • Su X; School of Public Health, Chongqing Medical University, Chongqing, China.
  • Yuan S; Department of Radiation Oncology, Shandong Cancer Hospital, Shandong, China.
  • Lin H; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
J Natl Compr Canc Netw ; 21(8): 821-830.e3, 2023 08.
Article in En | MEDLINE | ID: mdl-37549911

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drugs, Chinese Herbal / Lung Neoplasms / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Risk_factors_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Natl Compr Canc Netw Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China